186 related articles for article (PubMed ID: 34503991)
1. Differential Susceptibilities of Catecholamines to Metabolism by Monoamine Oxidases.
Goldstein DS; Castillo G; Sullivan P; Sharabi Y
J Pharmacol Exp Ther; 2021 Nov; 379(3):253-259. PubMed ID: 34503991
[TBL] [Abstract][Full Text] [Related]
2. Neurotoxicity of MAO metabolites of catecholamine neurotransmitters: role in neurodegenerative diseases.
Burke WJ; Li SW; Chung HD; Ruggiero DA; Kristal BS; Johnson EM; Lampe P; Kumar VB; Franko M; Williams EA; Zahm DS
Neurotoxicology; 2004 Jan; 25(1-2):101-15. PubMed ID: 14697885
[TBL] [Abstract][Full Text] [Related]
3. Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.
Taylor TN; Alter SP; Wang M; Goldstein DS; Miller GW
Neuropharmacology; 2014 Jan; 76 Pt A(0 0):97-105. PubMed ID: 24025942
[TBL] [Abstract][Full Text] [Related]
4. Different metabolism of norepinephrine and epinephrine by catechol-O-methyltransferase and monoamine oxidase in rats.
Eisenhofer G; Finberg JP
J Pharmacol Exp Ther; 1994 Mar; 268(3):1242-51. PubMed ID: 8138937
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.
Goldstein DS; Jinsmaa Y; Sullivan P; Holmes C; Kopin IJ; Sharabi Y
J Pharmacol Exp Ther; 2016 Feb; 356(2):483-92. PubMed ID: 26574516
[TBL] [Abstract][Full Text] [Related]
6. Norepinephrine transmitter metabolite is a selective cell death messenger in differentiated rat pheochromocytoma cells.
Burke WJ; Schmitt CA; Gillespie KN; Li SW
Brain Res; 1996 May; 722(1-2):232-5. PubMed ID: 8813375
[TBL] [Abstract][Full Text] [Related]
7. Monoamine oxidase and catecholamine metabolism.
Kopin IJ
J Neural Transm Suppl; 1994; 41():57-67. PubMed ID: 7931266
[TBL] [Abstract][Full Text] [Related]
8. The Catecholaldehyde Hypothesis for the Pathogenesis of Catecholaminergic Neurodegeneration: What We Know and What We Do Not Know.
Goldstein DS
Int J Mol Sci; 2021 Jun; 22(11):. PubMed ID: 34206133
[TBL] [Abstract][Full Text] [Related]
9. 3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.
Goldstein DS; Jinsmaa Y; Sullivan P; Holmes C; Kopin IJ; Sharabi Y
Neurochem Res; 2016 Sep; 41(9):2173-8. PubMed ID: 27220335
[TBL] [Abstract][Full Text] [Related]
10. N-Acetylcysteine Prevents the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.
Goldstein DS; Jinsmaa Y; Sullivan P; Sharabi Y
Neurochem Res; 2017 Nov; 42(11):3289-3295. PubMed ID: 28840582
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of monoamine oxidase by moclobemide: effects on monoamine metabolism and secretion of anterior pituitary hormones and cortisol in healthy volunteers.
Koulu M; Scheinin M; Kaarttinen A; Kallio J; Pyykkö K; Vuorinen J; Zimmer RH
Br J Clin Pharmacol; 1989 Feb; 27(2):243-55. PubMed ID: 2469451
[TBL] [Abstract][Full Text] [Related]
12. The catecholaldehyde hypothesis: where MAO fits in.
Goldstein DS
J Neural Transm (Vienna); 2020 Feb; 127(2):169-177. PubMed ID: 31807952
[TBL] [Abstract][Full Text] [Related]
13. Neurotoxic catecholamine metabolite in nociceptors contributes to painful peripheral neuropathy.
Dina OA; Khasar SG; Alessandri-Haber N; Bogen O; Chen X; Green PG; Reichling DB; Messing RO; Levine JD
Eur J Neurosci; 2008 Sep; 28(6):1180-90. PubMed ID: 18783367
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of 3,4-dihydroxyphenylglycolaldehyde, the neurotoxic monoamine oxidase A metabolite of norepinephrine, in locus ceruleus cell bodies in Alzheimer's disease: mechanism of neuron death.
Burke WJ; Li SW; Schmitt CA; Xia P; Chung HD; Gillespie KN
Brain Res; 1999 Jan; 816(2):633-7. PubMed ID: 9878889
[TBL] [Abstract][Full Text] [Related]
15. 3,4-Dihydroxyphenylacetaldehyde and hydrogen peroxide generate a hydroxyl radical: possible role in Parkinson's disease pathogenesis.
Li SW; Lin TS; Minteer S; Burke WJ
Brain Res Mol Brain Res; 2001 Sep; 93(1):1-7. PubMed ID: 11532332
[TBL] [Abstract][Full Text] [Related]
16. Effects of induced fescue toxicosis on plasma and tissue catecholamine concentrations in sheep.
Henson MC; Piper EL; Daniels LB
Domest Anim Endocrinol; 1987 Jan; 4(1):7-15. PubMed ID: 3507886
[TBL] [Abstract][Full Text] [Related]
17. Biochemical characterization of the catecholaldehyde reactivity of L-carnosine and its therapeutic potential in human myocardium.
Nelson MM; Builta ZJ; Monroe TB; Doorn JA; Anderson EJ
Amino Acids; 2019 Jan; 51(1):97-102. PubMed ID: 30191330
[TBL] [Abstract][Full Text] [Related]
18. Enhanced Catecholamine Flux and Impaired Carbonyl Metabolism Disrupt Cardiac Mitochondrial Oxidative Phosphorylation in Diabetes Patients.
Nelson MM; Efird JT; Kew KA; Katunga LA; Monroe TB; Doorn JA; Beatty CN; Shi Q; Akhter SA; Alwair H; Robidoux J; Anderson EJ
Antioxid Redox Signal; 2021 Aug; 35(4):235-251. PubMed ID: 33066717
[No Abstract] [Full Text] [Related]
19. Catecholamine degradation by monoamine oxidase in locus coeruleus neurons of the rat. An immunohistochemical study.
Kishimoto Y; Geffard M; Arai R
Brain Res; 2000 Mar; 859(2):373-7. PubMed ID: 10719089
[TBL] [Abstract][Full Text] [Related]
20. 3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing
Jinsmaa Y; Isonaka R; Sharabi Y; Goldstein DS
J Pharmacol Exp Ther; 2020 Feb; 372(2):157-165. PubMed ID: 31744850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
